Upstream Bio Inc (UPB)
8.00 x 3 13.96 x 1
Pre-market by (Cboe BZX)
8.78 +0.39 (+4.65%) 04/28/25 [NASDAQ]
8.00 x 3 13.96 x 1
Pre-market 8.78 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | UPB | RAPP | CELC | ||
| Company | Upstream Bio Inc | Rapport Therapeutics Inc | Celcuity Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.35 | 10.81 | 10.84 | ||
| High | 8.85 | 12.20 | 11.17 | ||
| Low | 7.93 | 10.70 | 10.59 | ||
| Last | 8.78 | 11.38 | 11.09 | ||
| Change | +0.39 | +0.76 | +0.29 | ||
| % Change | +4.65% | +7.16% | +2.69% | ||
| Volume | 291,500 | 395,100 | 265,300 | ||
| 20-Day Average Volume | 310,090 | 186,765 | 372,250 | ||
| Previous Close | 8.39 | 10.62 | 10.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.59 | 9.90 | 9.79 | ||
| 20-Day Raw Stochastic | 67.91% | 70.89% | 87.13% | ||
| 20-Day Relative Strength | 52.76% | 53.68% | 56.13% | ||
| Weighted Alpha | -53.91 | -46.87 | -27.99 | ||
| Today's Opinion | N/A | 56% Sell | 56% Sell | ||
| Previous Opinion | N/A | 56% Sell | 56% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.58% since 04/21/25 | +9.63% since 04/21/25 | +6.12% since 04/21/25 | ||
| Low | 7.93 on 04/28/25 | 10.30 on 04/22/25 | 10.50 on 04/22/25 | ||
| High | 10.50 on 04/23/25 | 12.85 on 04/23/25 | 11.61 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +27.80% since 03/28/25 | +13.23% since 03/28/25 | +8.30% since 03/28/25 | ||
| Low | 5.14 on 04/09/25 | 7.80 on 04/09/25 | 7.57 on 04/08/25 | ||
| High | 10.50 on 04/23/25 | 12.85 on 04/23/25 | 11.61 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -10.86% since 01/28/25 | -21.14% since 01/28/25 | -1.77% since 01/28/25 | ||
| Low | 5.14 on 04/09/25 | 6.43 on 03/04/25 | 7.57 on 04/08/25 | ||
| High | 11.80 on 01/31/25 | 18.27 on 02/05/25 | 13.43 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | -63.76% since 10/28/24 | -54.89% since 10/28/24 | -29.54% since 10/28/24 | ||
| Low | 5.14 on 04/09/25 | 6.43 on 03/04/25 | 7.57 on 04/08/25 | ||
| High | 29.46 on 11/06/24 | 28.00 on 11/07/24 | 16.54 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 327,503 | 328,099 | 327,307 | ||
| Shares Outstanding, K | 53,689 | 36,496 | 37,839 | ||
| Annual Sales | 2,370,000 | 0 | 0 | ||
| Annual Net Income | -62,810,000 | -78,310,000 | -111,780,000 | ||
| Last Quarter Sales | 610,000 | 0 | 0 | ||
| Last Quarter Net Income | -15,990,000 | -19,980,000 | -36,650,000 | ||
| 60-Month Beta | N/A | N/A | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -6.96 on 11/07/24 | -0.57 on 03/11/25 | -0.85 on 03/31/25 | ||
| Latest Earnings Date | 06/11/25 | 06/02/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||